Palantir Insider Files Sale Notice for 375K Shares via UBS on 08/20/2025

Rhea-AI Filing Summary

Palantir Technologies Inc. (PLTR) Form 144 notice records a proposed sale of 375,000 common shares through UBS Financial Services (NASDAQ) with an aggregate market value of $57,112,500 and an approximate sale date of 08/20/2025. The filer reports the shares were acquired the same day via exercise of stock options from the issuer and paid in cash. The filing also discloses three insider sales by Shyam Sankar during the prior three months totaling 577,545 shares for gross proceeds of $75,644,363.59. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Filer complied with Rule 144 notice requirements by disclosing the proposed sale and acquisition details
• Acquisition method disclosed: shares were acquired via exercise of stock options and paid in cash
• Broker identified (UBS Financial Services) and an approximate sale date (08/20/2025) are provided

Negative

• Substantial insider selling reported in prior three months: 577,545 shares sold for gross proceeds of $75,644,363.59
• No 10b5-1 plan date provided in the filing, so it's not specified whether sales follow a pre-established trading plan

Insights

Securities Analyst

TL;DR: Routine insider sale filing showing option exercise and a planned block sale via UBS on 08/20/2025.

The Form 144 documents a proposed sale of 375,000 common shares acquired by exercise of stock options and paid in cash, to be executed through UBS. Recent insider activity shows three sales by Shyam Sankar in May and June 2025 totaling 577,545 shares for about $75.6 million. This filing is procedural under Rule 144 to notify the market of an intended sale by an insider and does not itself provide company operational or financial updates.

Corporate Governance Expert

TL;DR: Filing complies with disclosure rules; multiple recent insider sales are documented but no new governance events are reported.

The notice indicates compliance with Rule 144 disclosure requirements and includes the required attestation regarding material undisclosed information. The report of both option exercise and subsequent planned sale is typical for insiders monetizing equity. There is no mention of any trading plan adoption date or 10b5-1 instruction in the filing text provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc. 11 Madison Avenue 4th Floor New York NY 10010	375000	57112500.00	2274261581	08/20/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/20/2025	Exercise of stock options	Issuer			375000	08/20/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Shyam Sankar 1200 17TH STREET FLOOR15 Denver CO 80202	Common	05/20/2025	150814	19061901.78
Shyam Sankar 1200 17TH STREET FLOOR 15 Denver CO 80202	Common	05/21/2025	16731	2107520.81
Shyam Sankar 1200 17TH STREET FLOOR 15 Denver CO 80202	Common	06/10/2025	405000	53490942.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many PLTR shares are proposed for sale in this Form 144?

The filing shows a proposed sale of 375,000 common shares with an aggregate market value of $57,112,500.

When is the approximate date of the proposed sale for PLTR shares?

The approximate date of sale listed in the filing is 08/20/2025.

How were the shares being sold in the Form 144 acquired?

The shares were acquired on 08/20/2025 by exercise of stock options from the issuer and payment was cash.

What insider sales occurred in the prior three months for PLTR?

The filing discloses three sales by Shyam Sankar: 150,814 shares on 05/20/2025; 16,731 shares on 05/21/2025; and 405,000 shares on 06/10/2025, totaling 577,545 shares for gross proceeds of $75,644,363.59.

Through which broker will the proposed PLTR sale be executed?

The broker named in the filing is UBS Financial Services Inc. (11 Madison Avenue, New York, NY).